California Clinical Trials

Glendale, California 91206

0 studies enrolling now · 12 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Depression, Depressive Disorder, Endocrine System Diseases, Gonadal Disorders, Healthy, Hypogonadism, Hypogonadism, Male, Parkinson's Disease, Schizophrenia, Schizophrenia, Schizoaffective Disorder

Studies at this site

• A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms — Stopped early
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia — Completed
• A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics — Completed
• A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males — Stopped early
• Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions — Stopped early
• A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease — Stopped early
• Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects — Completed
• Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189 — Completed
• Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl — Completed
• Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects — Completed
• Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease — Stopped early